Difficulty: Medium
Average Score: 88%
Practice
Gemfibrozil (Lopid) increases concentrations of HDL cholesterol more than clofibrate (Atromid-S). This consideration is:
Correct answer
A
Rationale
In the context of pharmacological lifespan treatment, understanding the effects of different medications on lipid profiles is crucial. In this case, the statement that Gemfibrozil (Lopid) increases concentrations of HDL cholesterol more than clofibrate (Atromid-S) is TRUE.
Gemfibrozil is a fibric acid derivative that primarily acts by increasing the activity of lipoprotein lipase, leading to a decrease in triglyceride levels and a modest increase in HDL cholesterol levels. On the other hand, clofibrate also belongs to the fibric acid derivative class but has been shown to be less effective than gemfibrozil in increasing HDL cholesterol levels.
Therefore, option A is correct as Gemfibrozil is indeed more effective in increasing HDL cholesterol concentrations compared to clofibrate. Option B is incorrect as it contradicts the known pharmacological effects of these medications. Options C and D are also incorrect as they do not accurately reflect the specific comparison between Gemfibrozil and clofibrate.
Educationally, this question highlights the importance of understanding the mechanisms of action and specific effects of different medications within the same class. It also emphasizes the need for healthcare professionals to be able to differentiate between drug properties to make informed decisions when selecting the most appropriate treatment for patients with dyslipidemia.
Gemfibrozil is a fibric acid derivative that primarily acts by increasing the activity of lipoprotein lipase, leading to a decrease in triglyceride levels and a modest increase in HDL cholesterol levels. On the other hand, clofibrate also belongs to the fibric acid derivative class but has been shown to be less effective than gemfibrozil in increasing HDL cholesterol levels.
Therefore, option A is correct as Gemfibrozil is indeed more effective in increasing HDL cholesterol concentrations compared to clofibrate. Option B is incorrect as it contradicts the known pharmacological effects of these medications. Options C and D are also incorrect as they do not accurately reflect the specific comparison between Gemfibrozil and clofibrate.
Educationally, this question highlights the importance of understanding the mechanisms of action and specific effects of different medications within the same class. It also emphasizes the need for healthcare professionals to be able to differentiate between drug properties to make informed decisions when selecting the most appropriate treatment for patients with dyslipidemia.